Main Management Fund Advisors’s KraneShares MSCI All China Health Care Index ETF KURE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-52,200
Closed -$18.9M 10
2022
Q1
$18.9M Buy
52,200
+3,700
+8% +$90.8K 12.24% 3
2021
Q4
$19.3M Sell
48,500
-23,900
-33% -$822K 13.74% 3
2021
Q3
$2.71M Buy
72,400
+2,400
+3% +$93.6K 2.09% 7
2021
Q2
$3.19M Sell
70,000
-66,200
-49% -$2.82M 2.51% 6
2021
Q1
$5.3M Buy
+136,200
New +$5.57M 4.63% 6

Other funds holding KURE

Main Management Fund Advisors's KURE Position: Q2 2022 in Review

Main Management Fund Advisors sold out of KraneShares MSCI All China Health Care Index ETF (KURE) in Q2 2022, closing a stake of 52,200 shares — an estimated $18.9M sold.

Main Management Fund Advisors first reported a position in KURE in Q1 2021 and held it in 5 quarters. The position peaked at $19.3M in Q4 2021. 19 funds tracked by Wall St. Rank hold KURE as of Q2 2022.

  • Main Management Fund Advisors reported no remaining KraneShares MSCI All China Health Care Index ETF position as of Q2 2022 after selling out during the quarter.
  • Main Management Fund Advisors sold 52,200 KraneShares MSCI All China Health Care Index ETF shares in Q2 2022, an estimated $18.9M.
  • Main Management Fund Advisors first reported a position in KraneShares MSCI All China Health Care Index ETF in Q1 2021 and held it in 5 quarters.
  • Main Management Fund Advisors's KraneShares MSCI All China Health Care Index ETF position peaked at $19.3M in Q4 2021.
  • 19 funds tracked by Wall St. Rank held KraneShares MSCI All China Health Care Index ETF as of Q2 2022.

Based on Main Management Fund Advisors's 13F filing for Q2 2022, filed 11 Aug 2022.